Evox Therapeutics is a biotechnology company developing exosome-based gene editing therapies. It develops ExoEdit, a CRISPR/Cas-based genome editing platform encapsulated within exosome-based nanoparticles that transport gene editing tools directly into hard-to-reach tissues. The therapy is dedicated to patients suffering from rare neurological and neurodegenerative diseases.